Awards and Recognitions

  • Asia Money Brokers Poll: Most Improved Brokerage in the Last 12 months – 2011
  • The StarMine Awards: Best India Brokerage Research Firm – March 2011

  • The Asset: Best Private Equity Deal of the Year in Southeast Asia – August 2010
    - For RCM role as an Advisor in the sale of Fortis Healthcare stake in Parkway Holdings Ltd to Khazanah Nasional

  • The M&A Atlas Awards: India M&A outbound deal of the year (Asia-Pac awards) – March 2010
    - For RCM role as an Advisor in the stake acquisition by Fortis Healthcare in Parkway Holdings Ltd

  • The M&A Atlas Awards: India corporate M&A deal of the year (Asia-Pac awards) – August 2009
    - For RCM role as an Advisor in the acquisition by Fortis Healthcare of Wockhardt Hospitals

  • The M&A Advisor: Excellence in deal making in the healthcare/life sciences category (>US$100mn) – June 2008
    - For RCM role as an Advisor in the sale of Ranbaxy Laboratories Limited to Daiichi Sankyo

   SFO

   RIO

   NYC

   LON

   DOH

   DUB

   DEL

   KL

   SIN

   JAK

   HKG

   TOK
Religare Capital Markets Limited, India: Member: NSE: SEBI Registration No. INB231302630, INF231302630, INE231302630 TM Code: 13026  BSE: SEBI Registration No. INB011302636, INF011302636. TM Code: 3240 I SEBI Merchant Banking Registration No.: INM000011062